Literature DB >> 15769823

The spectrum of infection-related morbidity in hospitalized haemodialysis patients.

Michael Allon1, Milena Radeva, James Bailey, Srinivasan Beddhu, David Butterly, Daniel W Coyne, Thomas A Depner, Jennifer J Gassman, Allen M Kaufman, George A Kaysen, Julia A Lewis, Steve J Schwab.   

Abstract

BACKGROUND: Infection is a common cause of mortality and morbidity in haemodialysis patients. Few prospective studies have examined the clinical consequences of infection-related hospitalizations in haemodialysis patients or the risk factors predictive of clinical outcomes.
METHODS: The outcomes of all first infection-related hospitalizations of patients enrolled in the HEMO Study were categorized in terms of mortality, requirement for intensive care unit (ICU) stay and length of hospitalization. In addition, the association of hospitalization outcomes with clinical and laboratory parameters was evaluated.
RESULTS: Among the 783 first infection-related hospitalizations, 57.7% had a severe outcome (death, ICU stay or hospitalization >/=7 days). The likelihood of a severe outcome increased with patient age (P<0.0001) and with decreased serum albumin (P<0.001). The frequency of a severe outcome varied greatly by infectious disease category (P<0.001), being highest for cardiac infections (95.6%) and infection of unknown source (68.4%), and lowest for urinary tract infections (35.5%) and access-related infections (43.8%). On multivariate analysis, hospitalization outcome was independently associated with patient age, serum albumin and disease category, but not with the randomized Kt/V or flux, gender, race or diabetic status.
CONCLUSION: In summary, infection-related hospitalizations are associated with substantial morbidity. Patient age, serum albumin and infectious disease category are independently correlated with the hospitalization outcome, and can be used to estimate the likelihood of serious outcomes at the time of hospital admission.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15769823     DOI: 10.1093/ndt/gfh729

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  26 in total

1.  Recommendations for the assessment and reporting of multivariable logistic regression in transplantation literature.

Authors:  A C Kalil; J Mattei; D F Florescu; J Sun; R S Kalil
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

2.  Outcomes of infection-related hospitalization in Medicare beneficiaries receiving in-center hemodialysis.

Authors:  Lorien S Dalrymple; Yi Mu; Patrick S Romano; Danh V Nguyen; Glenn M Chertow; Cynthia Delgado; Barbara Grimes; George A Kaysen; Kirsten L Johansen
Journal:  Am J Kidney Dis       Date:  2015-01-30       Impact factor: 8.860

3.  Clinical predictors of decline in nutritional parameters over time in ESRD.

Authors:  Claire H den Hoedt; Michiel L Bots; Muriel P C Grooteman; Neelke C van der Weerd; E Lars Penne; Albert H A Mazairac; Renée Levesque; Peter J Blankestijn; Menso J Nubé; Piet M ter Wee; Marinus A van den Dorpel
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 8.237

4.  Outcomes of Infection-Related Hospitalization according to Dialysis Modality.

Authors:  Louis-Philippe Laurin; Hind Harrak; Naoual Elftouh; Denis Ouimet; Michel Vallée; Jean-Philippe Lafrance
Journal:  Clin J Am Soc Nephrol       Date:  2015-03-27       Impact factor: 8.237

5.  Low Vitamin D and High Fibroblast Growth Factor 23 Serum Levels Associate with Infectious and Cardiac Deaths in the HEMO Study.

Authors:  Michel Chonchol; Tom Greene; Yingying Zhang; Andrew N Hoofnagle; Alfred K Cheung
Journal:  J Am Soc Nephrol       Date:  2015-05-13       Impact factor: 10.121

6.  CKD and Risk for Hospitalization With Infection: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Junichi Ishigami; Morgan E Grams; Alexander R Chang; Juan J Carrero; Josef Coresh; Kunihiro Matsushita
Journal:  Am J Kidney Dis       Date:  2016-11-22       Impact factor: 8.860

7.  eGFR and the Risk of Community-Acquired Infections.

Authors:  Hong Xu; Alessandro Gasparini; Junichi Ishigami; Khaled Mzayen; Guobin Su; Peter Barany; Johan Ärnlöv; Bengt Lindholm; Carl Gustaf Elinder; Kunihiro Matsushita; Juan Jesús Carrero
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-17       Impact factor: 8.237

8.  Association of dialysis modality with risk for infection-related hospitalization: a propensity score-matched cohort analysis.

Authors:  Jean-Philippe Lafrance; Elham Rahme; Sameena Iqbal; Naoual Elftouh; Michel Vallée; Louis-Philippe Laurin; Denis Ouimet
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-16       Impact factor: 8.237

9.  Treatment of catheter-related bacteremia with tissue plasminogen activator antibiotic locks.

Authors:  Ali Mirza Onder; Jayanthi Chandar; Nancy Simon; Marie Saint-Vil; Denise Francoeur; Obioma Nwobi; Carolyn Abitbol; Gaston Zilleruelo
Journal:  Pediatr Nephrol       Date:  2007-12-06       Impact factor: 3.714

10.  Rationale and design of the HEALTHY-CATH trial: a randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients.

Authors:  Jennifer K Broom; Stacey O'Shea; Sridevi Govindarajulu; E Geoffrey Playford; Carmel M Hawley; Nicole M Isbel; Scott B Campbell; David W Mudge; Sally Carpenter; Barbara C Johnson; Neil P Underwood; David W Johnson
Journal:  BMC Nephrol       Date:  2009-08-20       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.